ATE479427T1 - Pharmazeutische zusammensetzung mit candesartan- cilexetil - Google Patents

Pharmazeutische zusammensetzung mit candesartan- cilexetil

Info

Publication number: ATE479427T1
Authority: AT; Austria
Prior art keywords: cilexetil; pharmaceutical composition; composition containing; containing candesartan; candesartan
Prior art date: 2007-03-08

Application number

AT08726666T

Other languages

English (en)

Inventor

Minutza Leibovici

Itamar Kanari

Michael Fox

Original Assignee

Teva Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-08

Filing date

2008-03-10

Publication date

2010-09-15

2008-03-10 Application filed by Teva Pharma filed Critical Teva Pharma

2010-09-15 Application granted granted Critical

2010-09-15 Publication of ATE479427T1 publication Critical patent/ATE479427T1/de

Links

GHOSNRCGJFBJIB-UHFFFAOYSA-N Candesartan cilexetil Chemical compound C=12N(CC=3C=CC(=CC=3)C=3C(=CC=CC=3)C3=NNN=N3)C(OCC)=NC2=CC=CC=1C(=O)OC(C)OC(=O)OC1CCCCC1 GHOSNRCGJFBJIB-UHFFFAOYSA-N 0.000 title abstract 2
229960004349 candesartan cilexetil Drugs 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
150000001413 amino acids Chemical class 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

AT08726666T 2007-03-08 2008-03-10 Pharmazeutische zusammensetzung mit candesartan- cilexetil ATE479427T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US90615007P	2007-03-08	2007-03-08
PCT/US2008/003169 WO2008109170A1 (en)	2007-03-08	2008-03-10	Pharmaceutical composition comprising candesartan cilexetil

Publications (1)

Publication Number	Publication Date
ATE479427T1 true ATE479427T1 (de)	2010-09-15

Family

ID=39428075

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08726666T ATE479427T1 (de)	2007-03-08	2008-03-10	Pharmazeutische zusammensetzung mit candesartan- cilexetil

Country Status (8)

Country	Link
US (1)	US20090048316A1 (de)
EP (1)	EP2019668B1 (de)
AT (1)	ATE479427T1 (de)
CA (1)	CA2680449A1 (de)
DE (1)	DE602008002371D1 (de)
ES (1)	ES2351542T3 (de)
PT (1)	PT2019668E (de)
WO (1)	WO2008109170A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2009011493A (es) *	2007-04-25	2009-11-09	Teva Pharma	Complejo de excipiente farmaceutico.
RU2010104960A (ru) *	2007-08-01	2011-09-10	Тева Фармасьютикал Индастриес Лтд. (Il)	Фармацевтическая композиция кандесартана
EP2165702B1 (de) *	2008-09-17	2011-11-16	Helm AG	Durch Nassgranulation hergestellte stabile und fertig gelöste Zusammensetzungen aus Candesartan-Cilexetil
JP5917844B2 (ja) *	2011-06-24	2016-05-18	日本ケミファ株式会社	カンデサルタンシレキセチル製剤
CN102600140A (zh) *	2012-03-09	2012-07-25	迪沙药业集团有限公司	一种治疗高血压症的组合物
JP2018141011A (ja) *	2018-05-24	2018-09-13	日本ケミファ株式会社	カンデサルタンシレキセチル製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5196444A (en) *	1990-04-27	1993-03-23	Takeda Chemical Industries, Ltd.	1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US6300361B1 (en) *	1990-07-25	2001-10-09	Novartis Ag	Stabilized pharmaceutical compositions comprising acid donors
TW284688B (de) *	1991-11-20	1996-09-01	Takeda Pharm Industry Co Ltd
US20060029551A1 (en) *	2004-08-05	2006-02-09	Kui Liu	Stable particle formulations of erythropoietin receptor agonists
US20060165806A1 (en) *	2005-01-06	2006-07-27	Elan Pharma International Limited	Nanoparticulate candesartan formulations

2008
- 2008-03-10 DE DE602008002371T patent/DE602008002371D1/de active Active
- 2008-03-10 CA CA002680449A patent/CA2680449A1/en not_active Abandoned
- 2008-03-10 EP EP08726666A patent/EP2019668B1/de not_active Not-in-force
- 2008-03-10 US US12/075,414 patent/US20090048316A1/en not_active Abandoned
- 2008-03-10 WO PCT/US2008/003169 patent/WO2008109170A1/en not_active Ceased
- 2008-03-10 ES ES08726666T patent/ES2351542T3/es active Active
- 2008-03-10 PT PT08726666T patent/PT2019668E/pt unknown
- 2008-03-10 AT AT08726666T patent/ATE479427T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP2019668B1 (de)	2010-09-01
DE602008002371D1 (de)	2010-10-14
WO2008109170A1 (en)	2008-09-12
PT2019668E (pt)	2010-11-11
US20090048316A1 (en)	2009-02-19
CA2680449A1 (en)	2008-09-12
EP2019668A1 (de)	2009-02-04
ES2351542T3 (es)	2011-02-07

Similar Documents

Publication	Publication Date	Title
CY1126116T1 (el)	2023-11-15	Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη
CL2007002018A1 (es)	2008-05-09	Compuestos derivados de isoxazolinas sustituidas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para el tratamiento de una enfermedad causada por un aumento en la proliferacion celular.
EA201070786A1 (ru)	2011-02-28	Бензофуропиримидиноны
MX2009003038A (es)	2009-04-15	Derivados de quinazolinona 5-sustituidos como agentes antitumorales.
ATE540680T1 (de)	2012-01-15	Pharmazeutische aripiprazol-zusammensetzungen
IL195269A0 (en)	2009-08-03	Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
WO2006082523A3 (en)	2006-09-28	Pharmaceutical sustained release composition of metformin
TW200800967A (en)	2008-01-01	Benzimidazole thiophene compounds
CO6362017A2 (es)	2012-01-20	Peptidos antivirales terapeuticos
BRPI0815894A2 (pt)	2015-02-24	Composição farmacêutica, uso da mesma, e, sais farmaceuticamente aceitáveis de um composto.
CL2007003540A1 (es)	2008-06-13	Compuestos derivados de macrociclos, inhibidores de la proteasa serina de hepatitis c; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
MX2009013501A (es)	2010-01-18	Compuestos piperidinicos y sus usos.
ATE530170T1 (de)	2011-11-15	Paliperidonformulierung mit verzögerter freisetzung
WO2008006795A3 (en)	2008-03-06	Indole compounds
UA93709C2 (ru)	2011-03-10	12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
EA201170512A1 (ru)	2011-08-30	Композиция для перорального введения
DE602008002371D1 (de)	2010-10-14	Pharmazeutische zusammensetzung mit candesartan-cilexetil
IL209304A0 (en)	2011-01-31	Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
UY31758A (es)	2009-11-10	Forma cristalina anhidra de maleato de orvepitant
EA200900958A1 (ru)	2010-04-30	Препарат невирапина пролонгированного высвобождения
CL2009001089A1 (es)	2011-04-29	Compuestos derivados de indolo[2,1-a][2]benzacepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
WO2010079433A3 (en)	2010-12-29	Pharmaceutical composition comprising melogliptin
TW200718698A (en)	2007-05-16	Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
MX2008010233A (es)	2009-11-10	Composicion de liberacion modificada, que comprende doxofilina.
MX2012007393A (es)	2012-08-15	Composicion farmaceutica de disolucion rapida comprendiendo lornoxicam.

Legal Events

Date	Code	Title	Description
2011-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties